Bibiana Bielekova

Statistics

Publications

Citations

8.4K

H-Index

Active since

1999

Affiliations

National Institute of Neurological Disorders and Stroke(Current)

National Institutes of Health

National Institute of Allergy and Infectious Diseases

Montana State University

National Institutes of Health Clinical Center

Bibiana Bielekova is an author at National Institute of Neurological Disorders and Stroke specializing in life sciences, multiple sclerosis, and neuroimmunology.

ORCID

Publications per year

1999–2025

Publications

Cancer Regression and Neurological Toxicity Following Anti-MAGE-A3 TCR Gene Therapy

Richard A. Morgan, Nachimuthu Chinnasamy, Daniel Abate‐Daga et al. · Journal of Immunotherapy · 2013 · 1.1K citations

Life Sciences, Immunology, Neurology +17

Encephalitogenic potential of the myelin basic protein peptide (amino acids 83–99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand

Bibiana Bielekova, Bonnie L. Goodwin, Nancy Richert et al. · Nature Medicine · 2000 · 826 citations

Life Sciences, Neurology, Neuroscience +17

Regulatory CD56 <sup>bright</sup> natural killer cells mediate immunomodulatory effects of IL-2Rα-targeted therapy (daclizumab) in multiple sclerosis

Bibiana Bielekova, Marta Catálfamo, Susan Reichert-Scrivner et al. · Proceedings of the National Academy of Sciences · 2006 · 593 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon β

Bibiana Bielekova, Nancy Richert, Gregg Blevins et al. · Proceedings of the National Academy of Sciences · 2004 · 313 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +17

Meta-analysis of the Age-Dependent Efficacy of Multiple Sclerosis Treatments

Ann Marie Weideman, Marco Aurelio Tapia-Maltos, Kory Johnson et al. · Frontiers in Neurology · 2017 · 306 citations · Full text

Pharmacy, Biostatistics, Pharmacotherapy +16

1–5 of 83